Avidity Biosciences, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-06-11

Reporting Person: BOESS CARSTEN (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.82	2030-05-14	Common Stock (20858)		Direct

Footnotes

F1: 1/36th of the shares subject to the option vested on May 3, 2020, and 1/36th of the shares subject to the option will vest monthly thereafter.